Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of AERAS-402 in Adults Recently Treated for Pulmonary Tuberculosis
NCT02414828Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Oct 2008
- Primary completion
- Jul 2010
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of AERAS-402 in pulmonary tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started Oct 2008; status: completed.
02
Drugs
AERAS-402
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02414828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414828.